GE HealthCare Technologies (GEHC) Gains from Investment Securities (2022 - 2024)

GE HealthCare Technologies' Gains from Investment Securities history runs 3 years deep, the most recent figure standing at -$9.0 million for Q3 2024.

• Quarterly Gains from Investment Securities rose 35.71% year-over-year to -$9.0 million in Q3 2024, while the trailing twelve-month figure through Dec 2024 was -$19.0 million (down 11.76% YoY) and the FY2024 annual result came in at -$19.0 million, down 11.76% from the prior year.
• Gains from Investment Securities was -$9.0 million for Q3 2024 at GE HealthCare Technologies, roughly flat from -$9.0 million in the prior quarter.
• Across five years, Gains from Investment Securities topped out at -$1.0 million in Q1 2024 and bottomed at -$49.0 million in Q3 2022.
• A 3-year average of -$14.4 million and a median of -$9.0 million in 2024 frame the typical range for Gains from Investment Securities.
• Annual changes were most pronounced in 2023 — Gains from Investment Securities soared 71.43% — and 2024, when it plunged 200.0%.
• GE HealthCare Technologies' Gains from Investment Securities stood at -$16.0 million in 2022, then gained by 12.5% to -$14.0 million in 2023, then soared by 35.71% to -$9.0 million in 2024.
• Business Quant data shows GEHC's Gains from Investment Securities at -$9.0 million in Q3 2024, -$9.0 million in Q2 2024, and -$1.0 million in Q1 2024.